Bedaquiline-a potential inhibitor of COVID-19 main protease based on molecular docking. Int. J. of Res. in Pharmacology &Pharmacotherapeutics [Internet]. 2021 Mar. 27 [cited 2026 Apr. 17];9(2):136-44. Available from: https://ijrpp.com/ijrpp/article/view/29